Soha Ismail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Soha Ismail has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Abeer Khattab
Department of Pharmaceutics, National Organization for Drug Control and Research, Giza, Egypt.
2 shared publications Abeer Khattab
Egyptian Drug Author, Pharmaceut Dept, Cairo, Egypt
1 shared publication- Abeer Salama
Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, 12622, Egypt
1 shared publication Amany H. El-Shazly
Department of Pharmacology, Research Institute of Ophthalmology, Giza, Egypt
1 shared publicationAreeg M. Abd-Elrazek
Physiology Department, Egyptian Drug Authority, Cairo Governorate, Egypt
1 shared publication- Dalia M. N. Abouhussein
Affiliation Egyptian Drug Authority (EDA), Agouza, Giza, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (4) , 388
Preparation and Evaluation of Curcumin Nanocrystals for Topical Administration: Cell Line Analysis and Histopathological Examination
Purpose: The aim of this work is to enhance curcumin skin permeability through nanocrystals preparation. Methods: The bottom-up nanoprecipitation technique was used. Chitosan amount (X 1 ) and curcumin amount (X 2 ) were tested as the independent variables using a 3 1 × 2 1 full factorial design. Particle size (Y 1 ), zeta potential (Y 2 ), cumulative amount released (Q 24h ) (Y 3 ) and dissolution efficiency (%DE 24h ) (Y 4 ) were the dependent variables. The optimized formula was further characterized for any chemical or physical incompatibility, transmission electron microscopy, kinetics analysis of the in vitro release data, ex vivo permeability and retention study, the effect of storage at refrigerator, MTT assay and cell cycle analysis. Ex vivo histopathological examination was studied after incorporation in a gel base (FG). Results: Curcumin and chitosan were chemically compatible through Fourier Transform Infra-Red Spectroscopy. The selected formula (F3) showed birefringence under the polarized microscope indicating the crystalline form after preparation. Small particle size (155 nm), high zeta potential (+ 83.8 mV) and enhanced dissolution (Q 24h = 66.66% and DE 24h = 54.97%) were recorded. Transmission electron microscopy showed semispherical particles with shiny appearance. Ex vivo histopathological examination of curcumin nanocrystals gel proved biocompatibility. The formula also showed potent antiproliferative effect on the tested cell lines with the IC50 of 58 µg/mL. Conclusion: It could be concluded that curcumin nanocrystal gel is a promising topical delivery system.
- 1 April 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (4) , 388
Open AccessPreparation and Evaluation of Curcumin Nanocrystals for Topical Administration: Cell Line Analysis and Histopathological Examination
Purpose: The aim of this work is to enhance curcumin skin permeability through nanocrystals preparation. Methods: The bottom-up nanoprecipitation technique was used. Chitosan amount (X 1 ) and curcumin amount (X 2 ) were tested as the independent variables using a 3 1 × 2 1 full factorial design. Particle size (Y 1 ), zeta potential (Y 2 ), cumulative amount released (Q 24h ) (Y 3 ) and dissolution efficiency (%DE 24h ) (Y 4 ) were the dependent variables. The optimized formula was further characterized for any chemical or physical incompatibility, transmission electron microscopy, kinetics analysis of the in vitro release data, ex vivo permeability and retention study, the effect of storage at refrigerator, MTT assay and cell cycle analysis. Ex vivo histopathological examination was studied after incorporation in a gel base (FG). Results: Curcumin and chitosan were chemically compatible through Fourier Transform Infra-Red Spectroscopy. The selected formula (F3) showed birefringence under the polarized microscope indicating the crystalline form after preparation. Small particle size (155 nm), high zeta potential (+ 83.8 mV) and enhanced dissolution (Q 24h = 66.66% and DE 24h = 54.97%) were recorded. Transmission electron microscopy showed semispherical particles with shiny appearance. Ex vivo histopathological examination of curcumin nanocrystals gel proved biocompatibility. The formula also showed potent antiproliferative effect on the tested cell lines with the IC50 of 58 µg/mL. Conclusion: It could be concluded that curcumin nanocrystal gel is a promising topical delivery system.
- Open Access
- 17 September 2024
- Published by Elsevier in Scientific African
- Vol. 26
Anti-aging effect of mustard and flax seed oils based nanoemulsion gel on aged rat skin through antioxidant and anti-inflammatory activity
- 17 September 2024
- Published by Elsevier in Scientific African
- Vol. 26
Open AccessAnti-aging effect of mustard and flax seed oils based nanoemulsion gel on aged rat skin through antioxidant and anti-inflammatory activity
- Open Access
- 19 August 2024
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 10 (1) , 1-17
Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
Background: The present study aims to enhance the wound healing potential of the seed oil (SO) of Lagenaria siceraria (Egyptian cultivar) via the preparation of SO-loaded binary nanoethosomal (SO-BNE) gels. SO-BNEs were prepared using 23 factorial design, characterized for vesicle size, zeta potential, polydispersity index, linoleic and oleic acid EE% for ensuring improved skin permeability. The L. siceraria SO, optimized SO-BNE gels (0.5% and 5%) and Mebo® were topically applied in full-thickness wounded rat model twice daily for 10 days. Results: In the SO-BNE gel groups, the normal appearance of the skin architecture and structure of the dermis was revealed. In addition, the levels of NRF2, TGF-β1 and FOXO1, collagen type I, SMA-α and MIP2 were significantly elevated. The wound healing potential of SO-BNE gels was proposed to be via suppression of oxidative stress and stimulation of skin regeneration biomarkers. Furthermore, the SO screening through GC/MS unveiled high percentages of unsaturated fatty acids. SO was also found to be nontoxic to human skin fibroblast cells; enhanced viability and migration rates at concentration of 50 g/mL by 99.76% and 75.9%, respectively. Conclusion: These findings demonstrate that the Lagenaria siceraria SO-loaded BNE gels represent a promising delivery for wound healing with enhanced release and bioavailability.
- 19 August 2024
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 10 (1) , 1-17
Open AccessEnhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
Background: The present study aims to enhance the wound healing potential of the seed oil (SO) of Lagenaria siceraria (Egyptian cultivar) via the preparation of SO-loaded binary nanoethosomal (SO-BNE) gels. SO-BNEs were prepared using 23 factorial design, characterized for vesicle size, zeta potential, polydispersity index, linoleic and oleic acid EE% for ensuring improved skin permeability. The L. siceraria SO, optimized SO-BNE gels (0.5% and 5%) and Mebo® were topically applied in full-thickness wounded rat model twice daily for 10 days. Results: In the SO-BNE gel groups, the normal appearance of the skin architecture and structure of the dermis was revealed. In addition, the levels of NRF2, TGF-β1 and FOXO1, collagen type I, SMA-α and MIP2 were significantly elevated. The wound healing potential of SO-BNE gels was proposed to be via suppression of oxidative stress and stimulation of skin regeneration biomarkers. Furthermore, the SO screening through GC/MS unveiled high percentages of unsaturated fatty acids. SO was also found to be nontoxic to human skin fibroblast cells; enhanced viability and migration rates at concentration of 50 g/mL by 99.76% and 75.9%, respectively. Conclusion: These findings demonstrate that the Lagenaria siceraria SO-loaded BNE gels represent a promising delivery for wound healing with enhanced release and bioavailability.
- Open Access
- 27 June 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25 (6) , 1-15
Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
Our study aimed to explore the potential of using nanostructured lipid carriers (NLCs) to enhance the topical administration of β-sitosterol, a bioactive that is poorly soluble in water. Here, we have taken advantage of the unique characteristics that cubosomes have to provide as a drug delivery system. These characteristics include a large surface area, thermal stability, and the capacity to encapsulate molecules that are hydrophobic, amphiphilic, and hydrophilic. The cubosomal formulation was optimized by building a central composite design. The optimum dispersion exhibited a particle size of 88.3 nm, a zeta potential of -43, a polydispersity index of 0.358, and drug entrapment of 95.6%. It was composed of 15% w/w oleic acid and 5% w/w pluronic F127. The optimized cubosome dispersion was incorporated into a sponge formulation. The optimized cubosome sponge achieved a higher drug release compared with the cubosome dispersion. The SEM micrograph of the selected sponge showed that it has an interwoven irregular fibrous lamellar structure with low density and high porosity. The in-vivo data revealed that topical application of the β-sitosterol cubosomal sponge showed significant higher wound closure percentage relative to the β-sitosterol product (Mebo)®. Graphical Abstract
- 27 June 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25 (6) , 1-15
Open AccessMucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
Our study aimed to explore the potential of using nanostructured lipid carriers (NLCs) to enhance the topical administration of β-sitosterol, a bioactive that is poorly soluble in water. Here, we have taken advantage of the unique characteristics that cubosomes have to provide as a drug delivery system. These characteristics include a large surface area, thermal stability, and the capacity to encapsulate molecules that are hydrophobic, amphiphilic, and hydrophilic. The cubosomal formulation was optimized by building a central composite design. The optimum dispersion exhibited a particle size of 88.3 nm, a zeta potential of -43, a polydispersity index of 0.358, and drug entrapment of 95.6%. It was composed of 15% w/w oleic acid and 5% w/w pluronic F127. The optimized cubosome dispersion was incorporated into a sponge formulation. The optimized cubosome sponge achieved a higher drug release compared with the cubosome dispersion. The SEM micrograph of the selected sponge showed that it has an interwoven irregular fibrous lamellar structure with low density and high porosity. The in-vivo data revealed that topical application of the β-sitosterol cubosomal sponge showed significant higher wound closure percentage relative to the β-sitosterol product (Mebo)®. Graphical Abstract
- 9 May 2023
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 28 (5) , 425-439
Optimization of topical curcumin spanlastics for melanoma treatment
The aim of the study was to enhance curcumin skin permeability through preparation of spanlastics. Spanlastics were prepared using the ethanol injection technique throgth a central composite design using Span 60 concentration (X1), edge activator type (X2) and its concentration (X3) as the independent variables. The spanlastics were characterized for particle size (PS), encapsulation efficiency (EE) and dissolution efficiency (%DE24h). Formulae with the highest desirability (FN1 and FN2) were prepared and further characterized. They were elastic, spherical, non irritant, and compatible with the used excipients. They had particle sizes of 147 and 198 nm, encapsulation efficiencies of 84.00% and 89.63%, zeta potential values of -45.50 and -39.10 mV, permeation enhancement ratios of 11.51 and 8.34 folds, and amounts retained of 7.25 and 10.44 µg/cm2 after 24 hours, respectively. Formulae FN1 and FN2 showed cytotoxic effects after 48 hours on human melanoma A375 with IC50 of 10.9 and 75.6 μg/mL, respectively. They increased the apoptotic effect confirming the success of the spanlastics to be a potential delivery for melanoma treatment.
- 9 May 2023
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 28 (5) , 425-439
Optimization of topical curcumin spanlastics for melanoma treatment
The aim of the study was to enhance curcumin skin permeability through preparation of spanlastics. Spanlastics were prepared using the ethanol injection technique throgth a central composite design using Span 60 concentration (X1), edge activator type (X2) and its concentration (X3) as the independent variables. The spanlastics were characterized for particle size (PS), encapsulation efficiency (EE) and dissolution efficiency (%DE24h). Formulae with the highest desirability (FN1 and FN2) were prepared and further characterized. They were elastic, spherical, non irritant, and compatible with the used excipients. They had particle sizes of 147 and 198 nm, encapsulation efficiencies of 84.00% and 89.63%, zeta potential values of -45.50 and -39.10 mV, permeation enhancement ratios of 11.51 and 8.34 folds, and amounts retained of 7.25 and 10.44 µg/cm2 after 24 hours, respectively. Formulae FN1 and FN2 showed cytotoxic effects after 48 hours on human melanoma A375 with IC50 of 10.9 and 75.6 μg/mL, respectively. They increased the apoptotic effect confirming the success of the spanlastics to be a potential delivery for melanoma treatment.
- 17 January 2022
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 32 (4) , 354-364
Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
Currently, travoprost is a synthetic prostaglandin F2α analogue used in the treatment of glaucoma, it is delivered by eye drop solution. Due to its very low bioavailability and patient non-compliance, the objective of the current study was to enhance its bioavailability, and prolong its release Spanlastic nano-vesicles gels were designed and optimized using Box-Behnken design. The optimized spanlastic nano-vesicles gel exhibited the lowest particle size (PS), polydispersity index (PDI) and the highest zeta potential (ZP), encapsulation efficiency (EE) and mucoadhesive strength was fabricated into spanlastic nano-vesicles ocular insert by solvent casting. In vivo studies showed enhanced bioavailability of travoprost spanlastic nano-vesicles gel and ocular insert compared to the marketed eye drops (travoswix®), as proven by their higher Cmax and AUC0-∞, in addition to being nonirritant to ocular surfaces. However, spanlastic nano-vesicles ocular insert showed more prolonged effect than spanlastic nano-vesicles gel. According to our study, it can be suggested that travoprost spanlastic nano-vesicles ocular insert is a novel ocular delivery system for glaucoma treatment
- 17 January 2022
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 32 (4) , 354-364
Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
Currently, travoprost is a synthetic prostaglandin F2α analogue used in the treatment of glaucoma, it is delivered by eye drop solution. Due to its very low bioavailability and patient non-compliance, the objective of the current study was to enhance its bioavailability, and prolong its release Spanlastic nano-vesicles gels were designed and optimized using Box-Behnken design. The optimized spanlastic nano-vesicles gel exhibited the lowest particle size (PS), polydispersity index (PDI) and the highest zeta potential (ZP), encapsulation efficiency (EE) and mucoadhesive strength was fabricated into spanlastic nano-vesicles ocular insert by solvent casting. In vivo studies showed enhanced bioavailability of travoprost spanlastic nano-vesicles gel and ocular insert compared to the marketed eye drops (travoswix®), as proven by their higher Cmax and AUC0-∞, in addition to being nonirritant to ocular surfaces. However, spanlastic nano-vesicles ocular insert showed more prolonged effect than spanlastic nano-vesicles gel. According to our study, it can be suggested that travoprost spanlastic nano-vesicles ocular insert is a novel ocular delivery system for glaucoma treatment
- 6 February 2020
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (5) , 566-578
Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
The current work aimed to develop low-density gastroretentive sponges loaded with alfuzosin HCl (ALF) to sustain the rate of drug release, improve its oral bioavailability and deliver it to the main site of absorption. Sponges were developed, according to a 23 full factorial design, by compression of the lyophilized ALF-loaded hydroxypropylmethylcellulose (HPMC) or chitosan (CH) solutions. The influences of the polymer type, grade and concentration on the appearance, topography, porosity, density, in-vitro ALF release, floating behavior, swelling, erosion, and mucoadhesive potential of the developed sponges were explored. Based on the desirability value, the best achieved system was selected. The gastroretentive potential of this system was evaluated in healthy male volunteers via MRI. Soft and flexible sponges were developed. They were characterized with interconnecting pores and channels and had excellent floating properties with respect to floating lag time and duration. Compared to HPMC-based sponges, CH-based ones exhibited higher porosity, larger pore diameters, lower bulk densities, higher drug release rates, larger swelling ratios, faster erosion rates and better mucoadhesive properties. MRI of magnetite-loaded best-achieved CH-based system (F8) ascertained the development of a promising gastroretentive system; exhibiting a gastric residence period of at least 5 h.
- 6 February 2020
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (5) , 566-578
Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
The current work aimed to develop low-density gastroretentive sponges loaded with alfuzosin HCl (ALF) to sustain the rate of drug release, improve its oral bioavailability and deliver it to the main site of absorption. Sponges were developed, according to a 23 full factorial design, by compression of the lyophilized ALF-loaded hydroxypropylmethylcellulose (HPMC) or chitosan (CH) solutions. The influences of the polymer type, grade and concentration on the appearance, topography, porosity, density, in-vitro ALF release, floating behavior, swelling, erosion, and mucoadhesive potential of the developed sponges were explored. Based on the desirability value, the best achieved system was selected. The gastroretentive potential of this system was evaluated in healthy male volunteers via MRI. Soft and flexible sponges were developed. They were characterized with interconnecting pores and channels and had excellent floating properties with respect to floating lag time and duration. Compared to HPMC-based sponges, CH-based ones exhibited higher porosity, larger pore diameters, lower bulk densities, higher drug release rates, larger swelling ratios, faster erosion rates and better mucoadhesive properties. MRI of magnetite-loaded best-achieved CH-based system (F8) ascertained the development of a promising gastroretentive system; exhibiting a gastric residence period of at least 5 h.
- 1 February 2019
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 49, 383-395
Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
- 1 February 2019
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 49, 383-395
Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
- 1 December 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 48, 274-287
Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
- 1 December 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 48, 274-287
Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
- 1 June 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 45, 142-150
Optimization of proniosomal itraconazole formulation using Box Behken design to enhance oral bioavailability
- 1 June 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 45, 142-150
Optimization of proniosomal itraconazole formulation using Box Behken design to enhance oral bioavailability